INTERNATIONAL PATENT: JANSSEN BIOTECH, INC. FILES APPLICATION FOR "DOSES AND PHARMACEUTICAL COMPOSITIONS OF A CD33 X Vtriangle2 BISPECIFIC ANTIBODY FOR THE TREATMENT OF CANCER"

GENEVA, Feb. 17 -- JANSSEN BIOTECH, INC. (800/850 Ridgeview DriveHorsham, Pennsylvania 19044) filed a patent application (PCT/IB2025/058046) for "DOSES AND PHARMACEUTICAL COMPOSITIONS OF A CD33 X VDelta2 BISPECIFIC ANTIBODY FOR THE TREATMENT OF CANCER" on Aug 07, 2025. With publication no. WO/2026/033458, the details related to the patent application was published on Feb 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DASH, Ranjeet Prasad (c/o Janssen Research & Development, LLC920 US Route 202PO Box 300Raritan, New Jersey 08869), MCNAUGHTON, Brian Richard (c/o Janssen Research & Develop...